REG - Rentokil Initial PLC - Directorate Change

Rentokil InitialAnnouncement

Yesterday 07:00

For best results when printing this announcement, please click on link below:
https://newsfile.refinitiv.com/getnewsfile/v1/story?guid=urn:newsml:reuters.com:20260415:nRSO4790Aa&default-theme=true

RNS Number : 4790A  Rentokil Initial PLC  15 April 2026

 

 

15 April, 2026

 

Rentokil Initial plc appoints Thérèse Esperdy as Chair

 

Rentokil Initial plc (LSE: RTO, NYSE: RTO) ("the Company") today announces the
appointment of Thérèse Esperdy as Chair of the Board commencing 1 September
2026. She will join the Board as a Non-Executive Director and Chair-designate
on 1 July 2026.

 

This appointment follows the announcement on 5 March 2026 that Richard
Solomons, who has served as the Chair of the Company since 2019, had informed
the Board of his intention to retire from the Company.

 

Thérèse is currently Non-Executive Chair of Imperial Brands plc, a position
from which she will retire following their November 2026 Board meeting and FY
2026 results announcement, having served on the Board since July 2016. She is
also the Senior Independent Director designate of Smith & Nephew plc and a
Non-Executive Director of Moody's Corporation. Thérèse was previously Senior
Independent Director of National Grid plc.

 

In her executive career, Thérèse held senior leadership roles with JP Morgan
including Global Chair of their Financial Institutions Group, Co-head of
Asia-Pacific Corporate & Investment Banking and Global Head of Debt
Capital Markets.

 

Senior Independent Director, John Pettigrew, said:

 

"We are delighted to welcome Thérèse to Rentokil Initial. She brings
considerable experience to the Board from her wide-ranging non-executive roles
in international businesses based in both the UK and the US. The Board is
confident that she is the best possible candidate to lead the Board through
the exciting next phase of Rentokil Initial's growth, working with Mike and
the executive team.

 

"On behalf of the Board, I would like to thank Richard for his strong,
committed leadership and his significant contributions to the Company over
many years."

 

Thérèse Esperdy, incoming Chair, said:

 

"It's a privilege to be appointed as Chair of the Board, and I am looking
forward to working with my new colleagues to drive the Company forward and
realise the great potential it has as a leading global provider of pest
control and hygiene services."

 

Richard Solomons, outgoing Chair, said:

 

"It has been an immense privilege to serve as Chair of Rentokil Initial over
what has been a period of growth and transformation for the business. With the
successful appointment of Mike Duffy as CEO, and a clear strategy developed
for North American growth, 2026 is the right time for me to step down and
ensure a smooth handover to Thérèse. I have great confidence in the future
success of Rentokil Initial - it's a high-quality business, full of
exceptional people, operating in highly resilient growth markets."

Notes

 

The Board determined that Thérèse Esperdy is an independent Non-Executive
Director on appointment in accordance with the UK Corporate Governance Code.
She will succeed Richard Solomons as Chair of the Nomination Committee on 1
September 2026. There are no additional details to disclose under Listing Rule
6.4.8 in respect of the appointment. Thérèse will receive total fees of
£725,000 per annum. Richard Solomons will retire from the Board with effect
from midnight on 31 August 2026.

 

 

For further information, please contact:

 

Investors / Analysts: Heather Wood, Rentokil Initial plc, +44 7808 098793

Media: Malcolm Padley, Rentokil Initial plc, +44 7788 978199

 

About Rentokil Initial plc:

 

Rentokil Initial plc is a global leader in Pest Control and Hygiene &
Wellbeing services. It employs c.63,400 people in 90 countries.

 

www.rentokil-initial.com (https://www.rentokil-initial.com/)

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact
rns@lseg.com (mailto:rns@lseg.com)
 or visit
www.rns.com (http://www.rns.com/)
.

RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our
Privacy Policy (https://www.lseg.com/privacy-and-cookie-policy)
.   END  BOAGPUWPCUPQGBC



            Copyright 2019 Regulatory News Service, all rights reserved